CA2242913A1 - Inhibiteurs de la collagenase, a base d'acide hydroxamique - Google Patents
Inhibiteurs de la collagenase, a base d'acide hydroxamique Download PDFInfo
- Publication number
- CA2242913A1 CA2242913A1 CA002242913A CA2242913A CA2242913A1 CA 2242913 A1 CA2242913 A1 CA 2242913A1 CA 002242913 A CA002242913 A CA 002242913A CA 2242913 A CA2242913 A CA 2242913A CA 2242913 A1 CA2242913 A1 CA 2242913A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- benzyl
- compounds
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
On décrit des composés de la formule (I) ainsi que des dérivés de ceux-ci, acceptables sur le plan pharmacologique. Dans cette formule, R et R?3¿ représentent chacun indépendamment hydrogène, alkyle, alcényle, alcynyle ou aryle, R?1¿ représente arylméthyle et R?2¿ représente alkyle, alcényle, aryle, cycloalkyle ou cycloalcényle. Ces composés sont utiles dans le traitement et la prophylaxie de troubles dans lesquels une surproduction de CD23 soluble est impliquée.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9601041.8A GB9601041D0 (en) | 1996-01-17 | 1996-01-17 | Novel compounds |
GB9601041.8 | 1996-01-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2242913A1 true CA2242913A1 (fr) | 1997-07-24 |
Family
ID=10787226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002242913A Abandoned CA2242913A1 (fr) | 1996-01-17 | 1997-01-14 | Inhibiteurs de la collagenase, a base d'acide hydroxamique |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0912545A1 (fr) |
JP (1) | JP2000503312A (fr) |
KR (1) | KR19990077325A (fr) |
CN (1) | CN1213368A (fr) |
AR (1) | AR005472A1 (fr) |
AU (1) | AU725056B2 (fr) |
BR (1) | BR9707024A (fr) |
CA (1) | CA2242913A1 (fr) |
CZ (1) | CZ222498A3 (fr) |
GB (1) | GB9601041D0 (fr) |
HU (1) | HUP9901022A3 (fr) |
IL (1) | IL125381A0 (fr) |
NO (1) | NO983283L (fr) |
NZ (1) | NZ326352A (fr) |
PL (1) | PL327820A1 (fr) |
TR (1) | TR199801380T2 (fr) |
TW (1) | TW462967B (fr) |
WO (1) | WO1997026257A1 (fr) |
ZA (1) | ZA97345B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
GB9609795D0 (en) * | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
WO2000040713A1 (fr) * | 1999-01-06 | 2000-07-13 | Mcmaster University | Procede permettant de prevenir des reactions immunes et d'hypersensibilite |
GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
WO2002006227A1 (fr) * | 2000-07-18 | 2002-01-24 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de la metalloprotease matricielle |
CA2473754C (fr) * | 2002-01-28 | 2012-04-10 | Aimsco Limited | Traitement |
JPWO2006016399A1 (ja) | 2004-08-10 | 2008-05-01 | 株式会社静岡カフェイン工業所 | ヒドロキサム酸誘導体及びそれを有効成分とする医薬 |
KR100844277B1 (ko) * | 2005-04-29 | 2008-07-07 | (주)아모레퍼시픽 | 히드록삼산 유도체 및 이의 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB9504084D0 (en) * | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
-
1996
- 1996-01-17 GB GBGB9601041.8A patent/GB9601041D0/en active Pending
-
1997
- 1997-01-14 HU HU9901022A patent/HUP9901022A3/hu unknown
- 1997-01-14 TR TR1998/01380T patent/TR199801380T2/xx unknown
- 1997-01-14 BR BR9707024A patent/BR9707024A/pt unknown
- 1997-01-14 EP EP97901055A patent/EP0912545A1/fr not_active Withdrawn
- 1997-01-14 IL IL12538197A patent/IL125381A0/xx unknown
- 1997-01-14 JP JP9525693A patent/JP2000503312A/ja active Pending
- 1997-01-14 AU AU14436/97A patent/AU725056B2/en not_active Ceased
- 1997-01-14 CA CA002242913A patent/CA2242913A1/fr not_active Abandoned
- 1997-01-14 CN CN97192982A patent/CN1213368A/zh active Pending
- 1997-01-14 CZ CZ982224A patent/CZ222498A3/cs unknown
- 1997-01-14 WO PCT/EP1997/000196 patent/WO1997026257A1/fr not_active Application Discontinuation
- 1997-01-14 NZ NZ326352A patent/NZ326352A/xx unknown
- 1997-01-14 KR KR1019980705472A patent/KR19990077325A/ko not_active Application Discontinuation
- 1997-01-14 PL PL97327820A patent/PL327820A1/xx unknown
- 1997-01-15 AR ARP970100153A patent/AR005472A1/es unknown
- 1997-01-16 ZA ZA97345A patent/ZA97345B/xx unknown
- 1997-01-30 TW TW086101017A patent/TW462967B/zh active
-
1998
- 1998-07-16 NO NO983283A patent/NO983283L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO983283D0 (no) | 1998-07-16 |
HUP9901022A3 (en) | 2001-11-28 |
TW462967B (en) | 2001-11-11 |
AU725056B2 (en) | 2000-10-05 |
EP0912545A1 (fr) | 1999-05-06 |
AU1443697A (en) | 1997-08-11 |
CZ222498A3 (cs) | 1999-03-17 |
BR9707024A (pt) | 1999-07-20 |
NO983283L (no) | 1998-09-16 |
CN1213368A (zh) | 1999-04-07 |
KR19990077325A (ko) | 1999-10-25 |
IL125381A0 (en) | 1999-03-12 |
JP2000503312A (ja) | 2000-03-21 |
NZ326352A (en) | 2000-03-27 |
HUP9901022A2 (hu) | 1999-07-28 |
WO1997026257A1 (fr) | 1997-07-24 |
GB9601041D0 (en) | 1996-03-20 |
PL327820A1 (en) | 1999-01-04 |
ZA97345B (en) | 1998-07-16 |
AR005472A1 (es) | 1999-06-23 |
TR199801380T2 (xx) | 1998-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6235753B1 (en) | Inhibitors of the production of S-CD23 and the secretion of TNF | |
CA2242913A1 (fr) | Inhibiteurs de la collagenase, a base d'acide hydroxamique | |
WO2001085721A1 (fr) | Derives d'acide n-sulfonique hydroxamique en tant qu'inhibiteurs de cd23 | |
EP1448552B1 (fr) | Derives quinoleique, procede de preparation et utilisation de ceux-ci dans le traitement de maladies induites par s-cd23 | |
EP1224164B1 (fr) | Derive d'acide hydroxamique en tant qu'inhibiteur de formation du cd23 soluble humain | |
US5985838A (en) | Peptide analogs as irreversible interleukin-1β protease inhibitors | |
AU744801B2 (en) | Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF release | |
US7038055B2 (en) | Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies | |
WO2001044221A1 (fr) | Derives d'acide hydroxamique en tant qu'inhibiteurs du cd23 humain et de la liberation du facteur de necrose des tumeurs (tnf) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |